期刊文献+

固体脂质纳米粒在注射给药中的发展和应用

Development and application of solid lipid nanoparticles in the field of injection administration
下载PDF
导出
摘要 目的介绍固体脂质纳米粒(solid lipid nanoparticles,SLN)在注射给药中的发展和应用状况。方法与结果参考了29篇国内外有代表性的文献,综述了迄今SLN研究历程,其中包括SLN制备工艺、稳定性、生物利用度等,对比了几类胶体注射给药系统,指出固体脂质纳米粒在新药开发中的地位以及其在注射给药中的发展和应用。结论以生理相容的高熔点脂质为骨架材料制备的固体脂质纳米粒是一种极有发展潜力的新型给药系统的载体,其在注射给药中有广泛的应用前景。 Objective To introduce the development and application of solid lipid nanoparticles(SLN) in the field of injection administration. Methods and Results The formulation of SLN has lots of attractive characteristic, such as long-acting, low toxicity and good targeting. In this article, some important development about SLN, including preparation, stability as well as bioavailability, had been reviewed. Compared with several kinds of colloid disperse system that used in injection administration, we pointed out the application, important status and the development of SLN in the area of injection administration. Conclusions Solid lipid nanoparticles(SLN), prepared with biodegradable high-melting point lipids, has received more and more attention and been regarded as one of the most promising targeting and controlled-release DDS carriers. It will occupy the great markets of the world in the future.
作者 陈婷 王东凯
出处 《中国药剂学杂志(网络版)》 2007年第1期26-32,共7页 Chinese Journal of Pharmaceutics:Online Edition
关键词 药剂学 固体脂质纳米粒 注射给药途径 pharmaceutics solid lipid nanoparticles injection administration
  • 相关文献

参考文献21

二级参考文献65

  • 1张志荣,魏振平.载药毫微粒制备方法及药物靶向性[J].华西药学杂志,1996,11(2):123-136. 被引量:12
  • 2[1]Dienstag JL,Schiff ER,Mitchell M,et al.Extended Lamivudine retreatment for chronic hepatitis B[J].Hepatology,1996,24(1):188
  • 3[2]Muller RH,Mader K,Gohla S.Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art[J].Eur J Pharm Biopharm,2000,50(1):161
  • 4[3]Hashida M,Nishikawa M,Takakura Y.Hepatic targeting of drugs and proteins by chemical modification[J].J Controlled Release,1995,36(1/2):99
  • 5[4]Muller RH,Mehnert W,Lucks JS.Solid lipid nanoparticles (SLN)- an alternative colloidal carrier system for controlled drug delivery [J].Eur J Pharm Biopharm,1995,41:62
  • 6[5]Muller RH,Maassen S,Schwarz C.Solid lipid nanoparticles(SLN) as potential carrier for human use: interaction with human granulocytes[J].J Control Release,1997,47:261
  • 7[6]Muller RH,Ruhl D,Runge S,et al.Mehnert W.Cytotoxicity of Solid lipid nanoparticles as a function of the lipid matrix and the surfactant [J].Pharm Res,1997,14:458
  • 8[7]Schearz C,Mehnert W,Lucks JS,et al.Solid lipid nanoparticles (SLN) for controlled drug delivery.ⅠProduction,charecterazation and sterilization[J].J Control Release,1994,30(1):83
  • 9[1]Muller RH, Mehnert W, Lucks JS, et al. Solid lipid nanoparticles(SLN)-an alternative colloidal carrier system for controlled drug delivery [J]. Eur J Pharm Biopharm, 1995,41(1):62-69.
  • 10[2]De Vringer T, de Ronde HAG. Preparation and structure of a water-in-oil cream containing lipid nanoparticles [J]. J Pharm Sci, 1995,84(4):466-472.

共引文献141

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部